Document
IPR2018-01119, No. 2024 Exhibit - Comparison of Claims 1 15 of US 9,833,419 and US 9,724,310 (P.T.A.B. Aug. 22, 2018)
Cite Document
IPR2018-01119, No. 2024 Exhibit - Comparison of Claims 1 15 of US 9,833,419 and US 9,724,310 (P.T.A.B. Aug. 22, 2018)
+ More Snippets
Document
IPR2018-01119, No. 2004 Exhibit - J Hadgraft and R Guy, Feasibility Assessment in Topical and Transdermal Delivery, in TRANSDERMAL DRUG DELIVERY 3 4 R Guy J Hadgraft eds, 2d ed 200...
Cite Document
IPR2018-01119, No. 2004 Exhibit - J Hadgraft and R Guy, Feasibility Assessment in Topical and Transdermal Delivery, in TRANSDERMAL DRUG DELIVERY 3 4 R Guy J Hadgraft eds, 2d ed 2003 (P.T.A.B. Aug. 22
+ More Snippets
Document
IPR2018-01119, No. 2014 Exhibit - Google Scholar search results obtained March 7, 2018 ¿¿¿ citations of Kim et al, Penetration Enhancement of ¿¿2 Selective Agonist, Tulobuterol, Across Hairles...
Cite Document
IPR2018-01119, No. 2014 Exhibit - Google Scholar search results obtained March 7, 2018 ¿¿¿ citations of Kim et al, Penetration Enhancement of ¿¿2 Selective Agonist, Tulobuterol, Across Hairless Mouse
+ More Snippets
Document
IPR2018-01119, No. 2005 Exhibit - J Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery, 184 INTL J PHARMACEUTICS 1 6 1999 (P.T.A.B. Aug. 22, 2018)
Cite Document
IPR2018-01119, No. 2005 Exhibit - J Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery, 184 INTL J PHARMACEUTICS 1 6 1999 (P.T.A.B. Aug. 22, 2018)
+ More Snippets
Document
IPR2018-01119, No. 1034 Exhibit - EX1034 The Orange Book (P.T.A.B. May. 18, 2018)
Cite Document
IPR2018-01119, No. 1034 Exhibit - EX1034 The Orange Book (P.T.A.B. May. 18, 2018)
+ More Snippets
Document
MINIVELLE, 203752, Label (Orange Book Sep. 23, 2014)
Cite Document
MINIVELLE, 203752, Label (Orange Book Sep. 23, 2014)
+ More Snippets
Document
MINIVELLE, 203752, Letter (Orange Book Sep. 23, 2014)
Cite Document
MINIVELLE, 203752, Letter (Orange Book Sep. 23, 2014)
+ More Snippets
Document
MINIVELLE, 203752, Label (Orange Book Oct. 29, 2012)
Cite Document
MINIVELLE, 203752, Label (Orange Book Oct. 29, 2012)
+ More Snippets
Document
MINIVELLE, 203752, Review Clinical Pharmacology Biopharmaceutics Reviews (Orange Book Oct. 29, 2012)
Cite Document
MINIVELLE, 203752, Review Clinical Pharmacology Biopharmaceutics Reviews (Orange Book Oct. 29, 2012)
+ More Snippets
Document
MINIVELLE, 203752, Review Cross Discipline Team Leader Review (Orange Book Oct. 29, 2012)
Cite Document
MINIVELLE, 203752, Review Cross Discipline Team Leader Review (Orange Book Oct. 29, 2012)
+ More Snippets
Document
MINIVELLE, 203752, Review Statistical Review (Orange Book Oct. 29, 2012)
Cite Document
MINIVELLE, 203752, Review Statistical Review (Orange Book Oct. 29, 2012)
+ More Snippets
Document
MINIVELLE, 203752, Review Printed Labeling (Orange Book Oct. 29, 2012)
Cite Document
MINIVELLE, 203752, Review Printed Labeling (Orange Book Oct. 29, 2012)
+ More Snippets
Document
MINIVELLE, 203752, Review Approval Letters (Orange Book Oct. 29, 2012)
Cite Document
MINIVELLE, 203752, Review Approval Letters (Orange Book Oct. 29, 2012)
+ More Snippets
Document
MINIVELLE, 203752, Review Administrative Documents & Correspondence (Orange Book Oct. 29, 2012)
Cite Document
MINIVELLE, 203752, Review Administrative Documents & Correspondence (Orange Book Oct. 29, 2012)
+ More Snippets
Document
MINIVELLE, 203752, Review Other Reviews (Orange Book Oct. 29, 2012)
Cite Document
MINIVELLE, 203752, Review Other Reviews (Orange Book Oct. 29, 2012)
+ More Snippets